Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

This study has been completed.
Hadassah Medical Organization
Information provided by (Responsible Party):
Immunovative Therapies, Ltd. Identifier:
First received: November 13, 2007
Last updated: February 19, 2015
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)